Diagnostic and prognostic role of peritoneal CA 125 in peritoneal dialysis patients presenting with acute peritonitis

BMC Nephrology

Andrew Davenport¹  Kwanpeemai Panorchan¹ 

[1] UCL Centre for Nephrology, Royal Free Hospital, University College London Medical School, Rowland Hill Street, NW3 2PF London, UK

关键词: Peritoneal dialysis;    Gram-ve;    Gram + ve;    CA125;    Peritonitis;   

Others  :  1082620
DOI  :  10.1186/1471-2369-15-149

 received in 2014-02-09, accepted in 2014-09-10,  发布年份 2014

【 摘 要 】

Background

Cancer antigen 125 (CA125) is made by peritoneal mesothelial cells and can be measured in spent dialysate effluent from peritoneal dialysis (PD) patients. It has been suggested that CA125 is a marker of peritoneal mesothelial cell mass and turnover. As PD CA125 increases during peritoneal inflammation, we wished to determine whether measuring PD CA125 during peritonitis provided additional information in determining outcome of peritonitis.

Methods

We prospectively measured peritoneal CA125 in 127 adult PD patients presenting with 187 acute episodes of PD peritonitis, measuring peritoneal CA125 from a sample of dialysate effluent obtained from a 4 hour 2 litre 13.6 g/l dextrose peritoneal dwell.

Results

Mean patient age 60.8 ± 17.1 years, 62.6% male, 33.7% diabetic and the median PD vintage was 22 (11-48) months. 127 patients (66.8%) presented with their first episode of peritonitis, 20% their second episode, 13.2% third or greater. Gram positive bacteria accounted for 64.7% of all peritonitis episodes and Gram negative bacteria 21.1%. Treatment was successful for 151 episodes of PD peritonitis (81.1%). The median PD effluent total WBC was 1240 (430-3660) /ml and serum CRP 67 (20-144) mg/l, with a PD CA125 of 38 (20.3-72.3) IU/l on presentation. There were positive correlations between PD effluent CA125 concentrations and total WBC on presentation (r = 0.41, p = <0.001) and dialysis vintage (r = -0.43, p < 0.001) but not with patient age, diabetic status, or serum CRP.

There was no difference in PD effluent CA125 concentrations between Gram positive, and Gram negative peritonitis or between those episodes which responded to treatment, median 38 IU/ml (21-69) vs those with treatment failures 38 IU/ml (15-94).

Conclusion

We did not find any additional diagnostic or prognostic benefit for measuring effluent CA125 in PD patients presenting with acute peritonitis compared to standard investigations, including peritoneal WBC and serum CRP. As such our study would not support the routine measurement of peritoneal CA125 during episodes of peritonitis.

【 授权许可】

   
2014 Panorchan and Davenport; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Koomen GCM, Betjes MGH, Zemel D, Krediet RT, Hoek FJ: Dialysate cancer antigen (CA) 125 is a reflection of the peritoneal mesothelial mass in CAPD patients. Perit Dial Int 1994, 14:132-6.
• [2]Visser CE, Brouwer-Steenbergen JJ, Betjes MG, Koomen GC, Beeleen RH, Krediet RT: Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant 1995, 10:64-9.
• [3]Krediet RT: Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis. Perit Dial Int 2001, 21:560-7.
• [4]Ho-dac-Pannekeet MM, Hiralall JK, Struijk DG, Krediet RT: Longitudinal follow-up of CA-125 in peritoneal effluent. Kidney Int 1997, 51:888-93.
• [5]Habib AM, Preston E, Davenport A: Risk factors for developing encapsulating peritoneal sclerosis in the icodextrin era of peritoneal dialysis prescription. Nephrol Dial Transplant 2010, 25(5):1633-8.
• [6]Pannekeet MM, Zemel D, Koomen GC, Struijik DG, Krediet RT: Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD. Perit Dial Int 1995, 15:217-25.
• [7]Davenport A: Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003. Perit Dial Int 2009, 29:297-302.
• [8]Davenport A: Pan Thames Renal Audit Peritoneal Dialysis Group. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit. J Nephrol 2012, 25:819-24.
• [9]Elsurer R, Afsar B, Sezer S, Ozdemir FN: Peritoneal cells at admission: do they have prognostic significance in peritonitis? Ren Fail 2010, 32(3):335-42.
• [10]Chow KM, Szeto CC, Cheung KK, Leung CB, Wong SS, Law MC, Ho YW, Li PK: Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis. Clin J Am SocNephrol 2006, 1(4):768-73.
• [11]Dong J, Li Z, Xu R, Chen Y, Luo S, Li Y: Disease severity score could not predict the outcomes in peritoneal dialysis-associated peritonitis. Nephrol Dial Transplant 2012, 27(6):2496-501.
• [12]Li FK, Davenport A, Robson RL, Loetscher P, Rothlein R, Williams JD, Topley N: Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression. Kidney Int 1998, 54:2170-83.
• [13]Topley N, Liberek T, Davenport A, Li FK, Fear H, Williams JD: Activation of inflammation and leukocyte recruitment into the peritoneal cavity. Kidney Int Suppl 1996, 56:S17-21.
• [14]Davenport A, Fernando RL, Robson R, Varghese Z: Nitric oxide production by human peritoneal mesothelial cells. Int J Artif Organs 2004, 27(1):15-23.
• [15]Breborowicz A, Breborowicz M, Pyda M, Połubinska A, Oreopoulos D: Limitations of CA125 as an index of peritoneal mesothelial cell mass. NephronClinPract 2005, 100(2):c46-51.
• [16]Szeto CC, Kwan BC, Chow KM, Lau MF, Law MC, Chung KY, Leung CB, Li PK: Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases. Clin J Am SocNephrol 2008, 3(1):91-7.
• [17]Szeto CC, Kwan BC, Chow KM, Law MC, Pang WF, Leung CB, Li PK: Repeat peritonitis in peritoneal dialysis: retrospective review of 181 consecutive cases. Clin J Am SocNephrol 2011, 6(4):827-33.
• [18]Lai KN, Lai KB, Szeto CC, Ho KK, Poon P, Lam CW, Leung JC: Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters. Am J Kidney Dis 1997, 29:699-705.
• [19]Cheema H, Bargman J: Cancer antigen 125 as a biomarker in peritoneal dialysis: mesothelial cell health or death? PeritDialInt 2013, 33:349-352.